The September edition of the Journal of Drugs in Dermatology (JDD) focuses on aesthetic treatments, exploring the latest advancements and innovative approaches that are reshaping dermatologic care. This month’s Editor’s Picks bring together a selection of cutting-edge research, from the use of genomic analysis in melanoma management to AI’s influence on beauty standards.
Explore the latest aesthetic innovations and breakthroughs in dermatology by diving into this month’s Editor’s Picks from JDD.
Genomic Analysis Aids in the Management of Dermoscopically Atypical Pigmented Lesions reveals that non-invasive genomic testing, combined with clinical and dermoscopic features, enhances the differentiation of early melanoma in situ from atypical nevi, improving patent management decisions.
Effect of Topical Human Platelet Extract (HPE) for Facial Skin Rejuvenation: A Histological Study of Collagen and Elastin shows that topical HPE enhances facial skin health by promoting collagen and elastin formation in the dermis, with good tolerability and high participant satisfaction.
Data confirms that a well-formulated, OTC, multi-modal cosmetic regimen reduces facial erythema and improves skin appearance in A Cosmetic Regimen Formulated to Address the Multi-Modal Pathogenesis of Rosacea Demonstrates Efficacy for Treating Facial Redness and Skin’s Appearance
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel reviews the literature and develops seven key statements on the utility for the diagnosis and prediction of CM.
Algorithmic Beauty: The New Beauty Standard discusses AI’s role in shaping a patient’s visual diet.
Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions may serve as a promising new treatment option, addressing the limitations of current therapies in efficacy and side effects.
Find more JDD Issue Highlights here.
